Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
1 - 10 out of 137Page size: 10
Sort by: 1st author
  1. Published

    Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

    Abou-Alfa, G. K., Andersen, J. B., Chapman, W., Choti, M., Forbes, S. J., Gores, G. J., Hong, T. S., Harding, J. J., Vander Heiden, M. G., Javle, M., Kelley, R. K., Kwong, L. N., Lowery, M., Merrell, A., Miyabe, K., Rhim, A., Saha, S., Sia, D., Tanasanvimon, S., Venook, A. & 7 others, Valle, J. W., Walesky, C., Whetstine, J., Willenbring, H., Zhu, A. X., Mayer, D. & Stanger, B. Z., Dec 2016, In: Journal of Gastrointestinal Oncology. 7, 6, p. 819-827 9 p.

    Research output: Contribution to journal › Conference article › Research › peer-review

  2. Published

    MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism

    Akita, H., Marquardt, J. U., Durkin, M. E., Kitade, M., Seo, D., Conner, E. A., Andersen, Jesper Bøje, Factor, V. M. & Thorgeirsson, S. S., 4 Sep 2014, In: Cancer Research.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    Al-Abdulla, R., Lozano, E., Macias, R. I. R., Monte, M. J., Briz, O., O'Rourke, Colm, Serrano, M. A., Banales, J. M., Avila, M. A., Martinez-Chantar, M. L., Geier, A., Andersen, Jesper Bøje & Marin, J. J. G., 2019, In: British Journal of Pharmacology. 176, 6, p. 787-800

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Stromal yin-yang of myofibroblasts and endothelial cells in the progression of intrahepatic cholangiocarcinoma

    Andersen, Jesper Bøje, 2022, In: Hepatology. 76, 5, p. 1233-1236

    Research output: Contribution to journal › Editorial › Research

  5. Published

    Single cell profiling reveals window for immunotherapy in liver cancers

    Andersen, Jesper Bøje, 2018, In: Hepatobiliary surgery and nutrition. 7, 1, p. 48-51 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities

    Andersen, Jesper Bøje & Thorgeirsson, S. S., Apr 2013, In: Gastroenterology. 144, 4, p. 687-90 4 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  7. Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1

    Andersen, Jesper Bøje, Strandbygård, D. J., Hartmann, R. & Justesen, J., Feb 2004, In: European Journal of Biochemistry. 271, 3, p. 628-36 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

    Andersen, Jesper Bøje, Factor, V. M., Marquardt, J. U., Raggi, C., Lee, Y., Seo, D., Conner, E. A. & Thorgeirsson, S. S., 20 Oct 2010, In: Science Translational Medicine. 2, 54, p. 54ra77

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

    Andersen, Jesper Bøje, Mazan-Mamczarz, K., Zhan, M., Gorospe, M. & Hassel, B. A., 2009, In: RNA Biology. 6, 3, p. 305-15 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Fibrolamellar Hepatocellular Carcinoma: A Rare But Distinct Type of Liver Cancer

    Andersen, Jesper Bøje, 24 Feb 2015, In: Gastroenterology.

    Research output: Contribution to journal › Editorial › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 93714085